BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
VEGFA
,
Angiogenesis
,
HIV infection
,
Adipose tissue
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
atrophy of prostate
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Prostate gene expression in F3 descendents of rats treated with the endocrine disruptor vinclozolin
Explore Curated Studies Results
Literature
Most Relevant Literature
Prostatic atrophy. Clinicopathological significance.
Insulin-resistance reduces botulinum neurotoxin-type A induced prostatic atrophy and apoptosis in ra…
Focal prostatic atrophy: mimicry of prostatic cancer on TRUS and 3D-MRSI studies.
Mergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistoc…
Matrix metalloproteinase (MMP)-2 and MMP-9 activity and localization during ventral prostate atrophy…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Geographic Atrophy Treatment Evaluation
Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy
A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to A…
Prospective Validation of Prostate Biomarkers for Repeat Biopsy
A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ